Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest Pharmaceuticals

15:18 BST BerGenBio: Updated PhII Clinical Data With Selective AXL Inhibitor Bemcentinib Strengthens its Potential to Improve NSCLC Patient Outcomes

BerGenBio ASA (OSE: BGBIO) presented clinical data from its phase II programme with bemcentinib, a first-in-class highly selective oral AXL...


15:05 BST Adlai Nortye Opens New US Headquarters, Solidifying its Position in the Global Pharma Industry

Adlai Nortye Ltd. ("Adlai Nortye" or "the Company"), a leading biopharmaceutical company dedicated to the discovery and development of innovative...


14:00 BST New Trial Data: Senzer's Inhaler Delivers Cannabinoids Faster at Lower Doses

The physical uptake of pharmaceutical cannabinoids when inhaled through Senzer's unique respiratory device is more than 50 times faster than oral...


13:00 BST Daiichi Sankyo Initiates Two Phase 3 Trials of [Fam-] Trastuzumab Deruxtecan (DS-8201) in Patients with HER2 Positive Metastatic Breast Cancer including Head-to-Head Versus T-DM1 and Post-T-DM1 Study

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the first patients have been dosed in DESTINY-Breast03 and...


12:30 BST Ophthalmic Lasers Market to Reach US$ 1.44 Billion by 2024 end, Says TMR

The global ophthalmic lasers market features a fairly fragmented landscape despite the fact that the leading five players held a share of 35.0%...


10:10 BST Cancer Supportive Care Drugs Market Worth $23.5 Billion By 2022: Grand View Research, Inc.

The global cancer supportive care drugs market size is expected to be valued at USD 23.5 billion by 2022, as per a new report by Grand View...


09:20 BST Biosimilars Market Size Worth $61.47 Billion by 2025 | CAGR: 34.2%: Grand View Research, Inc.

The global biosimilars market size is expected to reach a value of USD 61.47 billion by 2025, according to a new report by Grand View Research,...


09:00 BST New Trial Data: Senzer's Inhaler Delivers Cannabinoids Faster at Lower Doses

The physical uptake of pharmaceutical cannabinoids when inhaled through Senzer's unique respiratory device is more than 50 times faster than oral...


09:00 BST The European Prevention of Alzheimer's Dementia (EPAD) Passes the Mark of 1,000 Participants for Its Longitudinal Cohort Study

The EPAD Longitudinal Cohort Study has recruited its 1,000th participant at the University of Oxford (UK). EPAD is one of the world leading...


07:24 BST Extraordinary General Meeting in Capio AB (publ)

The shareholders of Capio AB are hereby invited to attend the Extraordinary General Meeting (the "Meeting") for the primary purpose of resolving on...


07:22 BST Post-hoc Results From NEFIGAN Study to be Presented at the International IgA Nephropathy Network Meeting (IIgANN)

Calliditas Therapeutics AB (publ) ("Calliditas") today announced that post-hoc results from its clinical Phase 2b study NEFIGAN will be presented...


07:20 BST Capio Announces Notice of Extraordinary General Meeting and Information on the use of Proceeds from the Proposed Sale of Capio France

Capio today announces the notice of the Extraordinary General Meeting (the "EGM") convened to resolve on the Board's proposal to approve the sale...


07:00 BST AGC to Establish Mammalian cGMP-Compatible Contract Facility for Biopharmaceutical Development and Production at Chiba Plant

AGC, a world-leading manufacturer of glass, chemicals and high-tech materials, will be establishing a cGMP (*1)-compatible mammalian cell culture...


06:56 BST Precision Cancer Therapy With Elekta Unity now Available in the UK at The Royal Marsden and The Institute of Cancer Research, London

Elekta (EKTA-B.ST) today announced that The Royal Marsden and The Institute of Cancer Research (ICR), London, have clinically implemented Elekta...


06:13 BST Anaeropharma Science Signs Collaborative Research Agreement with Astellas on Creation of Novel Anti-Tumor Drugs Using Bifidobacterium

Anaeropharma Science Inc. headquartered in Tokyo (hereafter "Anaeropharma") announced on September 25 that Anaeropharma and Astellas Pharma Inc....


00:01 BST New Trial Data: Senzer's Inhaler Delivers Cannabinoids Faster at Lower Doses

The physical uptake of pharmaceutical cannabinoids when inhaled through Senzer's unique respiratory device is more than 50 times faster than oral...


24 Sep, 2018, 15:30 BST Daiichi Sankyo Presents Updated Results for [Fam-] Trastuzumab Deruxtecan (DS-8201) in Patients with HER2 Mutated or HER2 Expressing Non-Small Cell Lung Cancer at IASLC 19th World Conference on Lung Cancer

-- Updated subgroup analysis from ongoing phase 1 study of [fam-] trastuzumab deruxtecan (DS-8201) demonstrated a confirmed overall response rate...


24 Sep, 2018, 11:20 BST Sarcoma Drugs Market Size Worth $1.2 Billion by 2023 | CAGR: 8.5%: Grand View Research, Inc.

The global sarcoma drugs market size is expected to be valued at USD 1.2 billion by 2023, as per a new report by Grand View Research, Inc.,...


24 Sep, 2018, 11:00 BST Endo Agrees to Additional Stay of FDA Litigation Following FDA's Commitment to Use Best Efforts to Finalize Vasopressin Clinical Need Determination By Year End

Endo International plc (NASDAQ: ENDP) today announced that it has agreed to an additional stay of its litigation against the U.S. Food and Drug...


24 Sep, 2018, 10:10 BST Ingestible Sensors Market Worth $1.99 Billion by 2024 | CAGR 19.1%: Grand View Research, Inc.

The global ingestible sensors market size is expected to reach USD 1.99 billion by 2024, according to a new report by Grand View Research, Inc....


24 Sep, 2018, 10:00 BST NTC Explores a New Paradigma in Post Cataract Surgery

NTC, the Italian pharmaceutical company, presented at the ESCRS (European Society of Cataract & Refractive Surgeons) Congress of Vienna the...


24 Sep, 2018, 09:21 BST Oculis Appoints World-renowned Ophthalmology Specialist

Oculis, a clinical-stage biotechnology company developing next-generation topical treatments for acute and chronic back- and front-of-the-eye...


24 Sep, 2018, 09:00 BST Ferring Pharmaceuticals Announces UK Launch of Testavan® (Testosterone 2% Gel) for the Treatment of Male Hypogonadism

Ferring Pharmaceuticals today announced the launch of Testavan® 20 mg/g transdermal gel for the treatment of adult male hypogonadism. Testavan® is...


24 Sep, 2018, 09:00 BST Enesi Pharma and Walter Reed Army Institute of Research (WRAIR) Sign Cooperative R&D Agreement (CRADA) for Needle-Free Solid-Dose Vaccine for Shigella Infection

Enesi Pharma, an innovative pharmaceutical company developing unique injectable solid dose vaccine products, announces it has entered a...


21 Sep, 2018, 13:30 BST Microfluidics Market Will be Worth US$12.45 bn by 2025, Says TMR

The microfluidics technology which is nothing but the operating and controlling of liquids with flow channels has picked up a tremendous pace of...